Health
New evidence shows microbe strain can orally treat systemic inflammation in psoriasis – Science Codex
LUGANO, 29 October, 2020 – Disruptive innovations in psoriasis are leading the way at EADV’s 29th Congress, EADV Virtual. New data published today shows the first clinical evidence of modulating systemic inflammation by oral delivery of a non-living single strain commensal microbe. This new therapeutic class brings hope for a completely new way of treating this debilitating skin condition (1).
The phase 1b clinical study, by Evelo Biosciences, evaluated EDP1815, a preparation of a non-living single…
Continue Reading
-
General21 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General22 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Noosa News18 hours ago$20 million program to help women return to work
-
Noosa News18 hours agoSerious traffic crash, Noosa – Sunshine Coast